M. Mahajna et al., ACEPHATE INSECTICIDE TOXICITY - SAFETY CONFERRED BY INHIBITION OF THEBIOACTIVATING CARBOXYAMIDASE BY THE METABOLITE METHAMIDOPHOS, Chemical research in toxicology, 10(1), 1997, pp. 64-69
Acephate is an important systemic organophosphorus insecticide with to
xicity attributed to bioactivation on metabolic conversion to methamid
ophos (or an oxidized metabolite thereof) which acts as an acetylcholi
nesterase (AChE) inhibitor. The selective toxicity of acephate is cons
idered to be due to facile conversion to methamidophos in insects but
not mammals. We show in the present investigation that a carboxyamidas
e activates acephate in mice and in turn undergoes inhibition by the h
ydrolysis product, i.e., methamidophos; thus, the bioactivation is sta
rted but immediately turned off. These relationships are established b
y finding that 4 h pretreatment of mice with methamidophos ip at 5 mg/
kg has the following effects on acephate action: reduces methamidophos
and acephate levels in liver by 30-60% in the first 2 h after ip acep
hate dosage; inhibits the liver carboxyamidase cleaving [(CH3S)-C-14]a
cephate to [ (CH3S)-C-14]methamidiphos with 50% block at similar to 1
mg/kg; strongly inhibits (CO2)-C-14 liberation from [(CH3C)-C-14(O)]ac
ephate in. vivo; markedly alters the pattern of urinary metabolites of
acephate by increasing O- and S-demethylation products retaining the
carboxyamide moiety; greatly reduces the brain AChE inhibition followi
ng acephate treatment; doubles the LD(50) Of ip-administered acephate
from 540 to 1140 mg/kg. Methamidophos pretreatment in rats also marked
ly alters the metabolism of dimethoate (another systemic insecticide)
from principally carboxyamide hydrolysis to mainly other pathways. In
contrast, methamidophos pretreatment of houseflies does not alter the
acephate-induced toxicity and brain AChE inhibition. The safety of ace
phate in mammals therefore appears to be due to conversion in small pa
rt to methamidophos which, acting directly or as a metabolite, is a po
tent carboxyamidase inhibitor, thereby blocking further activation.